NAD+ is the oxidised form of nicotinamide adenine dinucleotide, a coenzyme present in every living cell. It is a dinucleotide, not a peptide, with a molecular weight of 663.43 g/mol for the free acid. In the laboratory it is studied as the electron-accepting partner in hundreds of dehydrogenase reactions and as the substrate consumed by sirtuins, poly(ADP-ribose) polymerases (PARPs) and NAD-glycohydrolases such as CD38. These roles make it a standard reagent in enzymology, cell-signalling and metabolism research. This article covers its structure, mechanisms, published literature, applications and the analytical and handling requirements that determine data quality.
What is NAD+?
Nicotinamide adenine dinucleotide consists of two nucleotides joined through their phosphate groups by a pyrophosphate bridge. One nucleotide carries an adenine base and the other carries nicotinamide, each attached to a ribose sugar. The molecular formula of the free acid is C21H27N7O14P2, with a molecular weight of 663.43 g/mol. The nicotinamide ring in the oxidised form carries a positive charge on the ring nitrogen, which is the origin of the “+” in the name. Commercial material is sold as the free acid or as a sodium salt, and the two differ in molecular weight and in how they behave when dissolved, so the form should be stated on the certificate of analysis.
The oxidised coenzyme absorbs ultraviolet light at 260 nm because of the adenine ring, with a molar absorptivity of about 18,000 M⁻¹cm⁻¹. Its reduced partner, NADH, has an additional absorbance band at 340 nm that NAD+ lacks, and this spectral difference underlies many classical enzyme assays.
The history begins with fermentation chemistry. In 1906, Arthur Harden and William John Young reported that cell-free yeast extract needed a heat-stable, dialysable factor, which they called a coferment, to continue fermenting sugar. Hans von Euler-Chelpin later worked out that the factor was a dinucleotide, and for decades it was known as diphosphopyridine nucleotide (DPN) or coenzyme I. In the 1930s, Otto Warburg showed that the nicotinamide ring is the site of hydride transfer, which established the coenzyme’s central role in biological oxidation-reduction.
Some practical terms cause confusion. “NAD” and “NAD+” are often used interchangeably in supplier catalogues, “NAD plus” is a common search variant, and NADH, NADP+ and NADPH are distinct compounds with different roles. Researchers should check that the certificate and the label name the same species.
Mechanism of action
Nicotinamide adenine dinucleotide acts through two broad mechanisms, and both matter for experimental design.
The first is redox chemistry. Dehydrogenases transfer a hydride ion (a proton with two electrons) from a substrate to the C4 position of the nicotinamide ring, converting NAD+ to NADH. The standard redox potential of the couple is about -0.32 V, which suits it to carrying reducing equivalents from catabolic reactions such as glycolysis, the citric acid cycle and fatty acid oxidation to the mitochondrial electron transport chain. The ratio of NAD+ to NADH, together with the separate pools in the cytosol and mitochondria, is an important measure of cellular metabolic state.
The second mechanism treats the coenzyme as a substrate consumed in a reaction. Sirtuins use it to remove acyl groups from lysine residues, cleaving the molecule and releasing nicotinamide. PARPs use it to build poly(ADP-ribose) chains in response to DNA damage. CD38 and related enzymes hydrolyse it to form signalling metabolites such as cyclic ADP-ribose. Each consuming reaction produces nicotinamide, which the cell recycles through the salvage pathway: nicotinamide phosphoribosyltransferase (NAMPT) converts it to nicotinamide mononucleotide (NMN), and NMN adenylyltransferases (NMNATs) regenerate the coenzyme. Cells can also synthesise it from tryptophan through the kynurenine pathway or from nicotinic acid through the Preiss-Handler route.
One design point deserves emphasis. Extracellular NAD+ is generally considered poorly permeable to intact cell membranes, and ectoenzymes such as CD38 and CD73 break it down outside the cell into metabolites that are then taken up. Researchers applying it to cultured cells should therefore not assume that the added molecule reaches the cytosol unchanged, and the question of how it enters cells remains an active area of debate in the literature.
What the research shows
Four bodies of published work frame the field.
The first is the discovery of the coferment. Harden and Young’s 1906 report in the Proceedings of the Royal Society showed that yeast juice lost fermenting activity after dialysis and recovered it when the dialysate was restored, which identified a small heat-stable cofactor. The result is a founding experiment in coenzyme biochemistry.
The second is the link between the coenzyme and gene silencing. Imai, Armstrong, Kaeberlein and Guarente reported in Nature in 2000 that the yeast protein Sir2 and its mouse homologue are NAD-dependent histone deacetylases, acting on lysines 9 and 14 of histone H3 and lysine 16 of histone H4. Their experiments used purified proteins and yeast genetics, and they proposed a molecular framework connecting metabolism, genomic silencing and ageing in yeast. The paper established that the coenzyme is a substrate for deacetylation, and it is indexed on PubMed.
The third is a synthesis of the biology of the coenzyme. Verdin’s 2015 review in Science described NAD+ as a coenzyme found in all living cells, serving both in redox reactions and as a cosubstrate for sirtuins and PARPs, and summarised how its biosynthesis and consumption are regulated and how cellular levels were reported to change in model organisms. It remains a standard entry point to the primary literature and is available on PubMed. Readers should note that it is a review, and that its discussion of intervention in whole organisms lies outside the scope of this laboratory-focused article.
The fourth is a research area, not a single paper: the consumption of the coenzyme after DNA damage. Cell-culture studies have repeatedly shown that strong PARP activation can deplete cellular NAD+ pools quickly, a finding that explains why PARP activity and sirtuin activity are often considered together. Readers should consult the primary literature for the specific cell type and damage model of interest, since the extent of depletion varies widely.
Research applications
Enzymology is the oldest and largest application. NAD+ is a substrate in assays for lactate dehydrogenase, alcohol dehydrogenase, glyceraldehyde-3-phosphate dehydrogenase and many other enzymes, and the increase in absorbance at 340 nm as NADH forms gives a direct kinetic readout. Enzymatic cycling assays, which amplify the signal, are used to quantify the coenzyme itself.
Sirtuin and PARP biochemistry is a second area. Purified enzyme assays use defined concentrations of the coenzyme with acetylated peptide substrates or histones to measure deacylase and ADP-ribosyltransferase activity, and kinetic studies determine Michaelis constants and test inhibitors. Cell-based research is a third area, in which scientists measure NAD+ and NADH pools by LC-MS, enzymatic cycling or fluorescent biosensors under different metabolic conditions, and manipulate biosynthesis by targeting NAMPT or NMNAT.
Analytical chemistry forms a fourth. The molecule is used as a calibrant for ion-pair and anion-exchange HPLC and as a standard in NMR and mass spectrometry. Finally, structural biologists use it and its analogues as ligands in crystallography and cryo-electron microscopy of dehydrogenases, sirtuins and NADases. For all of these, the purity and the exact form of the reagent affect the kinetic parameters obtained, which is why documentation matters.
Purity, storage and handling
Analytical verification starts with HPLC, usually by anion-exchange or ion-pair reversed-phase chromatography with detection at 260 nm. The main impurities to look for are nicotinamide and ADP-ribose from hydrolysis, NADH from reduction, and AMP or ADP from fragmentation. Identity can be confirmed by mass spectrometry and by ¹H and ³¹P NMR. Because UV purity does not prove biological function, an enzymatic assay, for example with alcohol dehydrogenase, shows what fraction of the material can act as a cofactor. Water content and the salt form should also be reported, since the powder is hygroscopic and a vial’s gross weight overstates its coenzyme content.
Because degradation accelerates once reconstituted, batch-level HPLC verification matters more here than with more stable reagents. UK laboratories sourcing Nad + should expect a batch-specific certificate of analysis and lyophilised storage at -20°C, and anyone comparing the best peptides supplier uk options can use the same documentation standards as a benchmark for any vendor.
A batch-specific certificate matters because hydrolysis products accumulate during manufacture and storage, and only a test on the batch in hand shows how much remains. The certificate should give the batch number, HPLC conditions and chromatogram, the identity method, the enzymatic or assay-based content, the water content, the salt form and the test date. Endotoxin testing is advisable for any cell-based work.
Lyophilised material is stored at -20°C, sealed and desiccated, and brought to room temperature before opening so that moisture does not condense on the powder. After reconstitution the coenzyme is much less stable. It is relatively stable in slightly acidic solution but breaks down in alkaline conditions, whereas NADH shows the opposite behaviour and degrades in acid. Water or a mildly acidic buffer is therefore usually preferred for stock solutions, with neutral assay buffers prepared close to the time of use. Stock solutions are normally held at 2-8°C for short periods and divided into single-use aliquots that are frozen, so that repeated freeze-thaw cycles are avoided. Exact stability windows depend on pH, buffer and temperature, so they should be taken from supplier data and confirmed in-house for critical assays.
Light sensitivity is modest for the oxidised form, but amber vials or dark storage are still sensible, since the reduced form and several impurities are more photosensitive and ultraviolet exposure can raise background absorbance in spectrophotometric assays. Standard COSHH assessment and institutional waste rules apply.
Frequently asked questions
Is NAD+ a peptide?
No. NAD+ is a dinucleotide coenzyme, made of an adenosine nucleotide and a nicotinamide nucleotide joined by a pyrophosphate bridge, with a molecular weight of 663.43 g/mol for the free acid. It is supplied as a lyophilised research reagent, which is why it is often handled alongside peptides.
What is the difference between NAD+ and NADH?
NAD+ is the oxidised form that accepts a hydride ion, and NADH is the reduced form that carries it. NADH absorbs at 340 nm while NAD+ does not, which underlies many enzyme assays. NAD+ is stable in acid and unstable in alkali, and NADH shows the reverse.
How should lyophilised NAD+ be stored?
Lyophilised NAD+ is generally stored at -20°C in a sealed, desiccated container protected from light, and warmed to room temperature before opening. Stock solutions are usually made in water or mildly acidic buffer, kept at 2-8°C briefly and frozen as single-use aliquots, with stability limits confirmed from batch data.
How is the purity of NAD+ verified?
Purity is usually measured by anion-exchange or ion-pair reversed-phase HPLC at 260 nm, with identity confirmed by mass spectrometry or NMR and functional content checked by an enzymatic assay. A good certificate also states water content, salt form and the test date for the specific batch.
NAD+ is supplied for in-vitro laboratory research only. It is not for human or veterinary use, and it must not be administered to people or animals.